Abstract
Hepatic encephalopathy (HE) is a neuropsychiatric syndrome associated with severe, acute and chronic liver failure. According to the recommendations of a working party (Ferenci et al., 2002) held at the 4th World Congress of Gastroenterology in Vienna in 1998, 3 types of HE should be differentiated, on principle:
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal, S., Kang, Y., DeWolf, A., Scott, V., Martin, M., Policare, R. 1993. Transcranial doppler monitoring of cerebral blood flow velocity during liver transplantation. Transplant Proc 25 (2): 1799–1800
Amodio, P., Gatta, A. 2005. Neurophysiological investigation of hepatic encephalopathy. Metabol Brain Dis 20 (4): 369–379
Amodio, P., Marchetti, P., Del Piccolo, F., de Tourtchaninoff, M., Varghese, P., Zuliani, C., Campo, G., Gatta, A., Guerit, J.M. 1999. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 110: 1334–1344
Atterbury, C.E., Maddrey, W., Conn, H.O. 1978. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis. 23: 398–406
Bajaj, J.S., Etemadian, A., Hafeezullah, M., Saeian, K. 2007a. Testing for minimal hepatic encephalopathy in the United States: An AASLD survey. Hepatology 45 (3): 833–834
Bajaj, J.S., Saeian, K., Verber, M.D., Hischke, D., Hoffmann, R.G., Franco, J., Varma, R.R., Rao, S.M. 2007b. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 102: 1–7
Bhatia, V., Batra, Y., Acharya, S.K. 2004. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure — a controlled clinical trial. J Hepatology 41: 89–96
Bhatia, V., Singh, R., Acharya, S.K. 2006. Predictive value of arterial ammonia for complications and outcome in acute liver failure. GUT 55 (1): 98–104
Bianchi, G.P., Marchesini, G., Fabbri, A., Rondelli, A., Bugianesi, E., Zoli, M., Pisi, E. 1993. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy: A randomized cross-over comparison. J Intern Med 233: 385–392
Blei, A.T., Olafsson, S., Webster, S., Levy, R. 1993. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 341: 157–158
Bustamante, J., Rimola, A., Ventura, P.J., Navasa, M., Cirera, I., Reggiardo, V., Rodes, J. 1999. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30: 890–895
Cadranel, J.F., Lebiez, E., Di Martino, V., Bernard, B., El Koury, S., Tourbah, A., Pidoux, B., Valla, D., Opolon, P. 2001. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: An underestimated entity. Am J Gastroenterol 96: 515–518
Campellone, J.V., Lacomis, D., Giuliani, M.J., Kroboth, F.J. 1996. Hepatic myelopathy. Case report with review of the literature. Clin Neurol Neurosurg 98: 242–246
Canalese, J., Gimson, A.E., Davis, C., Mellon, P.J., Davis, M., Williams, R. 1982. Controlled trial of dexamethasone and mannitol for the cerebral edema of fulminant hepatic failure. Gut 23: 625–629
Cordoba, J., Cabrera, J., Lataif, L., Penev, P., Zee, P., Blei, A.T. 1998. High prevalence of sleep disturbances in cirrhosis. Hepatology 27: 339–345
Cordoba, J., Lopez-Hellin, J., Planas, M., Sabin, P., Sanpedro, F., Castro, F., Esteban, R., Guardia, J. 2004. Normal protein diet for episodic hepatic encephalopathy: Results of a randomized study. J Hepatol 41: 38–43.
Davies, M.G., Rowan, M.J., Feely, J. 1991. EEG and event related potentials in hepatic encephalopathy. Metab Brain Dis 1991; 6: 175–186.
Ellis, A.J., Wendon, J.A., Williams, R. 2000. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: A controlled clinical trial. Hepatology 32: 536–541
Ferenci, P., Lockwood, A.H., Mullen, K., Tarter, R., Weissenborn, K., Blei, A.T. 2002. Hepatic encephalopathy — definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology. Vienna 1998; Hepatology 35(3): 716–721
Gitlin, N., Lewis, D.C., Hinkley, L. 1986. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy ambulant non-shunted patients with cirrhosis. J Hepatol 3: 75–82
Groeneweg, M., Quero, J.C., De Bruijn, I., Hartmann, I.J., Essink-bot, M.L., Hop, W.C., Schalm, S.W. 1998. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28: 45–49
Hartmann, I.J.C., Groeneweg, M., Quero, J.C., Beijeman, S.L., de Man, R.A., Hop, W.C., Schalm, S.W. 2000. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 2029–2034
Homburg, A.M., Jacobsen, M., Enevoldsen, E. 1993. Transcranial doppler recordings in raised intracranial pressure. Acta Neurol Scand 87: 488–493
Hui, A.Y., Chan, H.L., Leung, N.W., Hung, L.C., Chan, F.K., Sung, J.J. 2002. Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol 34(5): 569–572
Jalan, R., Olde Damink, S.W., Deutz, N.E., Hayes, P.C., Lee, A. 2004. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 127: 1338–1346
Kircheis, G., Nilius, R., Held, C., Berndt, H., Buchner, M., Görtelmeyer, R., Hendricks, R., Kruger, B., Kuklinski, B., Meister, H., Otto, H.J., Rink, C., Rosch, W., Stauch, S. 1997. Therapeutic efficacy of L-Ornithine-L-Aspartate infusions in patients With cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study. Hepatology 25: 1351–1360
Kircheis, G., Wettstein, M., Timmermann, L., Schnitzler, A., Haussinger, D. 2002. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 35: 357–366.
Krieger, S., Jauss, M., Jansen, O., Theilmann, L., Geissler, M., Krieger, D. 1996. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 111: 147–155
Kril, J.J., Butterworth, R.F. 1997. Diencephalic and cerebellar pathology in alcoholic and non-alcoholic patients with end-stage liver disease. Hepatology 26 (4): 837–841
Kullmann, F., Hollerbach, S., Holstege, A., Schölmerich, J. 1995. Subclinical hepatic encephalopathy: The diagnostic value of evoked potentials. J Hepatol 22: 101–110
Larsen, F.S., Ejlersen, E., Hansen, B.A., Knudsen, G.M., Tygstrup, N., Secher, N.H. 1995a. Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure. J Hepatol 23: 212–217
Larsen, F.S., Pott, F., Hansen, B.A., Ejlersen, E., Knudsen, G.M., Clemmesen, J.D., Secher, N.H. 1995b. Transcranial doppler sonography may predict brain death in patients with fulminant hepatic failure. Transpl Proc 27 (6): 3510–3511
Leevy, C.B., Phillips, J.A. 2007. Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy. Dig Dis Sci; 52: 737–741
Lockwood, A.H. 2000. “What’s in a name?” Improving the care of cirrhotics. J Hepatol 32: 859–861
Lockwood, A.H., Butterworth, R.F., Weissenborn, K. 1997. An image of the brain in liver disease. Curr Opin Neurol 10(6): 525–533
Lockwood, A.H., Murphy, B.W., Donnelly, K.Z., Mahl, T.C., Perini, S. 1993. Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 18 (5): 1061–1068
Lockwood, A.H., Weissenborn, K., Bokemeyer, M., Tietge, U., Burchert, W. 2002. Correlations between cerebral glucose metabolism and neuropsychological test performance in non-alcoholic cirrhotics. Metab Brain Dis 17(1): 29–40
Marchesini, G., Bianchi, G., Merli, M., Amodio, P., Panella, C., Loguercio, C., Rossi Fanelli, F., Abbiati, R., and Italian BCAA Study Group. 2003. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: A double-blind, randomized trial. Gastroenterology 124: 1792–1801
Marchesini, G., Fabbri, A., Bianchi, G., Brizi, M., Zoli, M. 1996. Zinc supplementation and amino-acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 23: 1084–1092
Mas, A., Rodes, J., Sunyer, L., Rodrigo, L., Planas, R., Vargas, V., Castells, L., Rodriguez-Martinez, D., Fernandez-Rodriguez, C., Coll, I., Pardo, A.;, Spanish Association for the study of the Liver Hepatic Encephalopathy Cooperative Group. 2003. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: Results of a randomized, double-blind, double-dummy, controlled clinical trial. J Hepatol. 38: 51–58.
Montagnese, S., Amodio, P., Morgan, M.Y. 2004. Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: A multidimensional approach. Metab Brain Dis 19: 281–312
Montagnese, S., Jackson, C., Morgan, M.Y. 2007. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. J Hepatol 46: 447–458
Morgan, M.Y., Alonso, M., Stanger, L.C. 1989. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. J Hepatol 8: 208–217
Morgan, M.Y., Hawley, K.E. 1987. Lactitol versus lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial. Hepatology 7(6): 1278–1284
Munoz, S.J. 1993. Difficult management problems in fulminant hepatic failure. Semin Liver Disease 13: 395–413
Murphy, N., Auzinger, G., Bernal, W., Wendon, J. 2004. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 39: 464–470
Muto, Y., Sato, S., Watanabe, A., Moriwaki, H., Suzuki, K., Kato, A., Kato, M., Nakamura, T., Higuchi, K., Nishiguchi, S., Kumada, H., Ohashi, Y.;, for the Long-Term-Survival Study (LOTUS) Group. 2005. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol. 3: 705–713.
O’Grady, J.G., Schalm, S.W., Williams, R. 1993. Acute liver failure: Redefining the syndromes. Lancet 342: 273–275
Ostapowicz, G.A., Fontana, R.J., Schiodt, F.V., Larson, A., Davern, T.J., Han, S.H., McCashland, T.M., Shakil, A.O., Hay, J.E., Hynan, L., Crippin, J.S., Blei, A.T., Samuel, G., Reisch, J., Lee, W.M.;, U.S. Acute Liver Failure Study Group. 2002. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137: 947–954
Parsons-Smith, B.G., Summerskill, W.H.J., Dawson, A.M., Sherlock, S. 1957. The electroencephalograph in liver disease. Lancet ii: 867–871
Penin, H. 1967. Über den diagnostischen Wert des Hirnstrombildes bei der hepato-portalen Encephalopathie. Fortschr Neurol Psychiatr 35 (4): 174–234
Polson, J., Lee, W.M. 2005. AASLD position paper: The management of acute liver failure. Hepatology 41(5): 1179–1197
Poo, J.L., Gongora, J., Sanchez-Avila, F., Aguilar-Castillo, S., Garcia-Ramos, G., Fernandez-Zertuche, M., Rodriguez-Fragoso, L., Uribe, M. 2006. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study. Ann Hepatol 5(4): 281–288
Powell, E.E., Pender, M.P., Chalk, J.B., Parkin, P.J., Strong, R., Lynch, S., Kerlin, P., Cooksley, W.G., Cheng, W., Powell, L.W. 1990. Improvement in chronic hepatocerebral degeneration following liver transplantation. Gastroenterology 98: 1079–1082
Prasad, S., Dhiman, R.K., Duseja, A., Chawla, Y.K., Sharma, A., Agarwal, R. 2007. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45: 549–559
Quadri, A.M., Ogunwale, B.O., Mullen, K.D. 2007. Can we ignore minimal hepatic encephalopathy any longer. Hepatology 45: 547–548
Raghavan, M., Marik, P.E. 2006. Therapy of intracranial hypertension in patients with fulminant hepatic failure. Neurocrit Care 4: 179–189
Riggio, O., Ariosto, F., Merli, M., Caschera, M., Zullo, A., Balducci, G., Ziparo, V., Pedretti, G., Fiaccodori, F., Bottari, E. et al. 1991. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy: results of a double-blind crossover trial. Dig Dis Sci 36: 1204–1208
Rinella, M.E., Sanyal, A. 2006. Intensive management of hepatic failure. Sem Respiratory Crit Care Med 27(3): 241–261
Romero-Gomez, M., Cordoba, J., Jover, R., Del Olmo, J.A., Ramirez, M., Rey, R., de Madaria, E., Montoliu, C., Nunez, D., Flavia, M., Company, L., Rodrigo, J.M., Felipo, V. 2007. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 45(4): 879–885
Sass, D.A., Shakil, A.O. 2005. Fulminant hepatic failure. Liver Transplantation 11(6): 594–605
Schnittger, C., Weissenborn, K., Böker, K., Kolbe, H., Dengler, R., Manns, M.P. 1997. Continuous noninvasive cerebral perfusion monitoring in fulminant hepatic failure and brain oedema. In Advances in Hepatic Encephalopathy & Metabolism in Liver Disease. eds C. Record and H. Al Mardini (eds.)., pp. 515–519. New Castle upon Tyne: Medical Faculty of the University of Newcastle upon Tyne
Schomerus, H., Hamster, W. 1998. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 13(4): 361–377
Schomerus, H., Hamster, W. 2001. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain 16 (1/2): 37–42
Schomerus, H., Hamster, W., Blunck, H., Reinhard, U., Mayer, K., Dolle, W. 1981. Latent portasystemic encephalopathy: I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 26: 622–630
Schomerus, H., Schreiegg, J. 1993. Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. Z Gastroenterol 31: 231–234
Schomerus, H., Weissenborn, K., Hamster, W., Rueckert, N., Hecker, H. 1999. PSE-syndrom-test. Psychodiagnostisches Verfahren zur quantitativen Erfassung der (minimalen) portosystemischen Enzephalopathie. Frankfurt: Swets Test Services.
Shami, V.M., Caldwell, S.H., Hespenheide, E.E., Arseneau, K.O., Blickston, S.J., Macik, B.G. 2003. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 9: 138–143
Sherlock, S., Summerskill, W.H.J., White, L.P., Phear, E.A. 1954. Portal-systemic encephalopathy. Neurological complications of liver disease. Lancet I: 453–457
Spahr, L., Butterworth, R.F., Fontaine, S., Bui, L., Therrien, G., Milette, P.C., Lebrun, L.H., Zayed, J., Leblanc, A., Pomier-Layrargues, G. 1996. Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996; 24: 1116–1120
Srivastava, A., Mehta, R., Rothke, S.P., Rademaker, A.W., Blei, A.T. 1994. Fitness to drive in patients with cirrhosis and portal systemic shunting: A pilot study evaluating driving performance. J Hepatol 21: 1023–1028
Stauch, S., Kircheis, G., Adler, G., Beckh, K., Ditschuneit, H., Görtelmeyer, R., Hendricks, R., Heuser, A., Karoff, C., Malfertheiner, P., Mayer, D., Rosch, W., Steffens, J. 1998. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: Results of a placebo-controlled double-blind study. J Hepatol 28: 856–864
Tofteng, F., Larsen, F.S. 2004. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 24: 798–804
Van der Rijt, C.D.C., Schalm, S., De Groot, G.H., De Vlieger, M. 1990. Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroencephalogr Clin Neurophysiol 75: 289–295
Van der Rijt, K., Schalm, S.W., Schat, H., Foeken, K., De Jong, G. 1991. Overt hepatic encephalopathy precipitated by zinc deficiency. Gastroenterology 100: 114–118
Vaquero, J., Fontana, R.J., Larson, A.M., Bass, N.M.T., Davern, T.J., Shakil, A.O., Han, S., Harrison, M.E., Stravitz, T.R., Munoz, S., Brown, R., Lee, W.M., Blei, A.T. 2005. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 12: 1581–1589
Victor, M., Adams, R.D., Cole, M. 1965. The acquired (non-Wilsonina) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 44: 345–394
Watanabe, A., Tuchida, T., Yata, Y., Kuwabara, J. 1995. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis. 10: 239–248
Wein, C., Koch, H., Popp, B., Oehler, G., Schauder, P. 2004. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 39: 739–745
Weissenborn, K. 1991. Neurophysiological methods in the diagnosis of Eearly hepatic encephalopathy. In Progress in Hepatic Encephalopathy and Metabolic Nitrogen Exchange. Bengtsson F, Jeppsson B, Almdal T, Vilstrup H (eds.)., pp 27–39. Boca Raton: CRC Press
Weissenborn, K., Ennen, J.C., Schomerus, H., Ruckert, N., Hecker, H. 2001. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 34: 768–773.
Weissenborn, K., Scholz, M., Hinrichs, H., Wiltfang, J., Schmidt, F.W., Künkel, H. 1990. Neurophysiological assessment of early hepatic encephalopathy. Electroencephalogr Clin Neurophysiol 1990; 75: 289–295
Weissenborn, K., Tietge, U.J., Bokemeyer, M., Mohammadi, B., Bode, U., Manns, M.P., Caselitz, M. 2003. Liver transplantation improves hepatic myelopathy: Evidence by three cases. Gastroenterology. 2003; 124: 346–351
White, M.L., Zhang, Y., Andrew, L.G., Hadley, W.L. 2005. MR imaging with diffusion-weighted imaging in acute and chronic wernicke encephalopathy. AJNR 26: 2306–2310
Zhong, C., Jin, L., Fei, G. 2005. MR imaging of nonalcoholic wernicke encephalopathy: A follow-up study. AJNR 26: 2301–2305
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Weissenborn, K. (2009). Hepatic Encephalopathy. In: McCandless, D. (eds) Metabolic Encephalopathy. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79112-8_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-79112-8_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-79109-8
Online ISBN: 978-0-387-79112-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)